396 related articles for article (PubMed ID: 31104211)
1. HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide.
Sugita J
Int J Hematol; 2019 Jul; 110(1):30-38. PubMed ID: 31104211
[TBL] [Abstract][Full Text] [Related]
2. Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide.
Sugita J; Kagaya Y; Miyamoto T; Shibasaki Y; Nagafuji K; Ota S; Furukawa T; Nara M; Akashi K; Taniguchi S; Harada M; Matsuo K; Teshima T;
Bone Marrow Transplant; 2019 Mar; 54(3):432-441. PubMed ID: 30087460
[TBL] [Abstract][Full Text] [Related]
3. [HLA-haploidentical transplantation with post-transplant cyclophosphamide].
Sugita J
Rinsho Ketsueki; 2017; 58(10):2124-2134. PubMed ID: 28978857
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant cyclophosphamide beyond haploidentical transplantation.
Arcuri LJ; Ribeiro AAF; Hamerschlak N; Kerbauy MN
Ann Hematol; 2024 May; 103(5):1483-1491. PubMed ID: 37261557
[TBL] [Abstract][Full Text] [Related]
5. [HLA-haploidentical stem cell transplantation].
Sugita J
Rinsho Ketsueki; 2023; 64(6):515-523. PubMed ID: 37407477
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide: A Systematic Review and Meta-Analysis Comparing Myeloablative with Reduced-Intensity Conditioning Regimens and Bone Marrow with Peripheral Blood Stem Cell Grafts.
Arcuri LJ; Hamerschlak N; Rocha V; Bonfim C; Kerbauy MN
Transplant Cell Ther; 2021 Sep; 27(9):782.e1-782.e7. PubMed ID: 34146733
[TBL] [Abstract][Full Text] [Related]
7. [Allogeneic hematopoietic stem cell transplantation using posttransplant cyclophosphamide].
Sugita J
Rinsho Ketsueki; 2020; 61(9):1402-1410. PubMed ID: 33162542
[TBL] [Abstract][Full Text] [Related]
8. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning.
Sugita J; Kawashima N; Fujisaki T; Kakihana K; Ota S; Matsuo K; Miyamoto T; Akashi K; Taniguchi S; Harada M; Teshima T;
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1646-52. PubMed ID: 26093044
[TBL] [Abstract][Full Text] [Related]
9. Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation.
Wada F; Kanda J; Kamijo K; Nishikubo M; Yoshioka S; Ishikawa T; Ueda Y; Akasaka T; Arai Y; Izumi K; Hirata H; Ikeda T; Yonezawa A; Anzai N; Watanabe M; Imada K; Yago K; Tamura N; Itoh M; Masuo Y; Kunitomi A; Takeoka T; Kitano T; Arima N; Hishizawa M; Asagoe K; Kondo T; Takaori-Kondo A
Cell Transplant; 2023; 32():9636897231194497. PubMed ID: 37646153
[TBL] [Abstract][Full Text] [Related]
10. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
Cieri N; Greco R; Crucitti L; Morelli M; Giglio F; Levati G; Assanelli A; Carrabba MG; Bellio L; Milani R; Lorentino F; Stanghellini MT; De Freitas T; Marktel S; Bernardi M; Corti C; Vago L; Bonini C; Ciceri F; Peccatori J
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1506-14. PubMed ID: 26001696
[TBL] [Abstract][Full Text] [Related]
11. Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation.
Sugita J; Kamimura T; Ishikawa T; Ota S; Eto T; Kuroha T; Miyazaki Y; Kumagai H; Matsuo K; Akashi K; Taniguchi S; Harada M; Teshima T
Bone Marrow Transplant; 2021 Mar; 56(3):596-604. PubMed ID: 32973350
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Study of an HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Regimen Based on Modification of the Dose of Posttransplant Cyclophosphamide for Poor Prognosis or Refractory Hematological Malignancies.
Nakamae H; Okamura H; Hirose A; Koh H; Nakashima Y; Nakamae M; Nishimoto M; Makuuchi Y; Kuno M; Harada N; Takakuwa T; Hino M
Cell Transplant; 2022; 31():9636897221112098. PubMed ID: 35906755
[TBL] [Abstract][Full Text] [Related]
13. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.
Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Montesinos P; Bermúdez A; de Laiglesia A; Herrera P; Martin C; Humala K; Zabalza A; Torres M; Bento L; Corral LL; Heras I; Serrano D; Buño I; Anguita J; Regidor C; Duarte R; Cabrera R; Gayoso J; Diez-Martin JL
Bone Marrow Transplant; 2017 Aug; 52(8):1138-1143. PubMed ID: 28346415
[TBL] [Abstract][Full Text] [Related]
14. Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide.
Willem C; Makanga DR; Guillaume T; Maniangou B; Legrand N; Gagne K; Peterlin P; Garnier A; Béné MC; Cesbron A; Le Bourgeois A; Chevallier P; Retière C
J Immunol; 2019 Apr; 202(7):2141-2152. PubMed ID: 30787107
[TBL] [Abstract][Full Text] [Related]
15. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Wiskott-Aldrich Syndrome With Myeloablative Conditioning.
Sharma A; Rastogi N; Kapoor R; Chatterjee G; Yadav SP
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e230-e233. PubMed ID: 32459721
[TBL] [Abstract][Full Text] [Related]
16. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
[TBL] [Abstract][Full Text] [Related]
17. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Slade M; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Romee R
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1736-1743. PubMed ID: 28688919
[TBL] [Abstract][Full Text] [Related]
18. How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.
McCurdy SR; Luznik L
Blood; 2019 Nov; 134(21):1802-1810. PubMed ID: 31751485
[TBL] [Abstract][Full Text] [Related]
19. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.
Ciurea SO; Zhang MJ; Bacigalupo AA; Bashey A; Appelbaum FR; Aljitawi OS; Armand P; Antin JH; Chen J; Devine SM; Fowler DH; Luznik L; Nakamura R; O'Donnell PV; Perales MA; Pingali SR; Porter DL; Riches MR; Ringdén OT; Rocha V; Vij R; Weisdorf DJ; Champlin RE; Horowitz MM; Fuchs EJ; Eapen M
Blood; 2015 Aug; 126(8):1033-40. PubMed ID: 26130705
[TBL] [Abstract][Full Text] [Related]
20. Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor.
Sugita J; Kuroha T; Ishikawa J; Eto T; Fukushima K; Yokota I; Akashi K; Taniguchi S; Harada M; Teshima T
Bone Marrow Transplant; 2024 Mar; 59(3):344-349. PubMed ID: 38114645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
